Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Ujhelyi

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Heart & Lung : the Journal of Critical Care|November 1, 1993
Spotlight article: quinidine enhances digitalis toxicity at therapeutic serum digoxin levels. (Mordel A, Halkin H, Zulty I, Almog S, Ezra D. Clin Pharm Ther 1993;53:457-62)M R Ujhelyi
Critical Care Medicine|October 23, 1997
Assessment of tricyclic antidepressant toxicity: looking for a needle in a pharmacologic haystackM R Ujhelyi
Critical Care Medicine|June 1, 1995
Lorazepam versus midazolam for sedationM R Ujhelyi
Clinical Pharmacokinetics|June 1, 1995
Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicityM R Ujhelyi, S Robert
Journal of Molecular and Cellular Cardiology|September 2, 1999
Action potentials that mimic fibrillation activate sodium currentM R Ujhelyi, T L Creazzo
Pharmacotherapy|January 1, 1991
Absorption of oral ciprofloxacin in a patient with cardiogenic shockM R Ujhelyi, M Sullivan, C Nightingale
Critical Care Medicine|October 1, 1994
Role of exogenous adenosine as a modulator of theophylline toxicityM R Ujhelyi, G Hulula, K A Skau
Critical Care Medicine|October 1, 1993
Reinstitution of digoxin after digoxin Fab antibody therapy in a hemodialyzed patientS Robert, M R Ujhelyi, B J Zarowitz
Therapeutic Drug Monitoring|October 18, 2000
Comparison of the pharmacokinetics and in vivo bioaffinity of DigiTAb versus DigibindS B Ward, L Sjostrom, M R Ujhelyi
Pharmacotherapy|December 17, 1997
Lidocaine does not affect myocardial electrical heterogeneity: implications for low proarrhythmic actionsJ J Sims, A P Winecoff, M R Ujhelyi
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Heart & Lung : the Journal of Critical Care|November 1, 1993
Spotlight article: quinidine enhances digitalis toxicity at therapeutic serum digoxin levels. (Mordel A, Halkin H, Zulty I, Almog S, Ezra D. Clin Pharm Ther 1993;53:457-62)M R Ujhelyi
Critical Care Medicine|October 23, 1997
Assessment of tricyclic antidepressant toxicity: looking for a needle in a pharmacologic haystackM R Ujhelyi
Critical Care Medicine|June 1, 1995
Lorazepam versus midazolam for sedationM R Ujhelyi
Clinical Pharmacokinetics|June 1, 1995
Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicityM R Ujhelyi, S Robert
Journal of Molecular and Cellular Cardiology|September 2, 1999
Action potentials that mimic fibrillation activate sodium currentM R Ujhelyi, T L Creazzo
Pharmacotherapy|January 1, 1991
Absorption of oral ciprofloxacin in a patient with cardiogenic shockM R Ujhelyi, M Sullivan, C Nightingale
Critical Care Medicine|October 1, 1994
Role of exogenous adenosine as a modulator of theophylline toxicityM R Ujhelyi, G Hulula, K A Skau
Critical Care Medicine|October 1, 1993
Reinstitution of digoxin after digoxin Fab antibody therapy in a hemodialyzed patientS Robert, M R Ujhelyi, B J Zarowitz
Therapeutic Drug Monitoring|October 18, 2000
Comparison of the pharmacokinetics and in vivo bioaffinity of DigiTAb versus DigibindS B Ward, L Sjostrom, M R Ujhelyi
Pharmacotherapy|December 17, 1997
Lidocaine does not affect myocardial electrical heterogeneity: implications for low proarrhythmic actionsJ J Sims, A P Winecoff, M R Ujhelyi
Pageof 5